Visby Medical’s focus is on bringing lab-quality molecular diagnostics directly to consumers. Founded in 2012, Visby Medical is revolutionizing infectious disease diagnosis by empowering patients to accurately test for infections anywhere, anytime, with laboratory accuracy. The company’s proprietary technology platform delivers true PCR results in 30 minutes through the world’s first instrument-free, single-use PCR tests that fit in the palm of your hand. The Women's Sexual Health Test is available for purchase outside the traditional clinical settings (over the counter, without a prescription), allowing users to perform accurate, rapid tests privately at home. The experience is supported by an app that helps interpret results and connect users with third-party telehealth providers, allowing the consumer to access same-day treatment when prescribed by the provider. Over time, Visby aims to expand this model to cover a broader range of conditions, positioning itself as a leader in the consumer molecular diagnostics market.
